Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

CRET therapy affects inflammation in skin cells by changing cytokine levels and activating certain proteins.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

PCOS involves immune and genetic factors, with key roles for T cells and specific genes.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Targeting Keratin 17 may help overcome cancer therapy resistance.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

Tph cells are linked to the severity of systemic lupus erythematosus.

A new genetic mutation in the CAST gene may link PLACK syndrome to alopecia areata.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Various skin conditions can be treated effectively with different methods, such as discontinuing certain drugs, using specific vaccines, applying creams, and changing lifestyle habits like smoking and drinking.

Low PON1 levels may indicate and predict the severity of hair loss.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

COVID-19 can harm male fertility by reducing sperm stem cells and damaging testicular function.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Sphingosine 1-phosphate affects inflammation and gene expression in different aorta cells.

S1PR1 helps control inflammation in blood vessel cells by affecting gene activity differently in various cell types and locations.

Helicobacter pylori infection is common in Southern Iraq gastritis patients, affecting 64.1%.

Some drugs may help treat both COVID-19 and radiation injury.

Dexamethasone may cause hair loss by stopping cell growth.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.